Chargement en cours...

RAS and BRAF in metastatic colorectal cancer management

The treatment of metastatic colorectal cancer (mCRC) has been further refined with the development of monoclonal antibodies, cetuximab and panitumumab, towards the epidermal growth factor receptor (EGFR). Anti-EGFR therapy has afforded improved survival in those with wild-type RAS mCRC but provides...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastrointest Oncol
Auteurs principaux: Gong, Jun, Cho, May, Fakih, Marwan
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5056249/
https://ncbi.nlm.nih.gov/pubmed/27747083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.06.12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!